Stay updated on Pembrolizumab vs Placebo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedStudy status updated to Completed as of 2026-03-17, and recruitment status updated on 2026-02-23 under revision v3.5.0. The previous status 'Active, not recruiting' was removed under revision v3.4.3.SummaryDifference0.4%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry v3.4.3 is added and the previous revision v3.4.2 is removed. This is a UI/versioning update that does not affect study data or results.SummaryDifference0.1%

- Check55 days agoChange DetectedThe history shows a new revision entry (v3.4.2) and removal of the previous revision (v3.4.1), a minor bookkeeping update to the record history; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page's revision label in the footer was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedNew revision entry v3.3.4 added and prior revision v3.3.3 removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check106 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Placebo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.